NASDAQ: SDGR · Life Sciences · 5 alerts · CIK 1490978
Share price
$27.36Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Schrodinger, Inc. filings on SEC EDGAR ↗
Schrodinger Insider Robert Lorne Abel Sells $803K of Stock
Robert Lorne Abel sold 23,605 shares of Schrodinger, Inc. at $34.00 a share, worth $803K in total on Nov 11, 2026. Shares held after the trade: 54,219 (-3.0%).
Yvonne Tran, EVP, CLO & Cpo, sold 32,000 shares of Schrodinger, Inc. at $29.97 to $33.11 a share (average $32.85) in 4 transactions, worth $1.05M in total on Nov 9, 2026. Shares held after the trade: 52,683 (-29.1%).
Schrodinger, Inc. reported its third quarter 2026 results, highlighting a history of operating losses and expectations for continued losses as it invests in its computational platform and proprietary drug discovery programs. The company is focused on leveraging its agentic AI co-scientist and strategic collaborations, such as with Novartis, to drive software growth and clinical advancement.
Schrodinger reported Q3 2026 financial results with total revenue of $64.5 million, a 19% increase year-over-year, driven by 17% growth in Annual Contract Value (ACV). The company raised its full-year 2026 guidance for both ACV and drug discovery revenue following strong software performance and a milestone payment from Structure Therapeutics.
Term
Q3 2026
“We are very pleased with our third quarter performance, delivering 17% ACV growth, $24 million of drug discovery revenue, and raising our full-year ACV and drug discovery revenue outlook. Our strong performance highlights the power of our industry-leading platform and also our business model in which our software and drug discovery businesses reinforce each other.”
Ramy Farid, Ph.D., chief executive officer of Schrödinger
Schrodinger Insider Karen Akinsanya Sells $928K of Stock
Karen Akinsanya sold 31,599 shares of Schrodinger, Inc. at $28.00 to $30.00 a share (average $29.37) in 2 transactions, worth $928K in total on Sep 17, 2026. Shares held after the trade: 69,956 (-23.6%).